Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

HealthEquity (HQY) is highlighted as a potential growth stock, despite its Zacks Rank #3 (Hold) rating, driven by a strong 'A' Growth Style Score and 'B' VGM Score. The company projects 24% year-over-year earnings growth for the current fiscal year, with analysts recently increasing fiscal 2026 earnings estimates to $3.87 per share. This, coupled with an average earnings surprise of +11.1%, positions HQY as a notable consideration for growth-oriented portfolios.

Analysis

HealthEquity (HQY) presents a compelling case for growth-oriented investors, underscored by its 'A' grade for Growth and 'B' for VGM in the Zacks Style Scores. The company is forecasting significant year-over-year earnings growth of 24% for the current fiscal year, a key indicator of its strong operational outlook. This positive forward momentum is further substantiated by recent analyst activity; for fiscal 2026, six analysts have revised their earnings estimates upward within the last 60 days, leading to a $0.14 increase in the Zacks Consensus Estimate to $3.87 per share. Historically, HQY has demonstrated an ability to outperform expectations, boasting an average earnings surprise of +11.1%. However, these strong growth signals are juxtaposed with a neutral Zacks Rank of #3 (Hold), suggesting that while the long-term fundamental picture is robust, there may be near-term factors, such as valuation or momentum, that temper its immediate upside potential according to the model.

Key Decisions for Investors

• Growth-focused investors should place HealthEquity on their watchlist, as its projected 24% earnings growth and 'A' Growth Score signal strong underlying fundamentals despite the neutral 'Hold' rating.
• The upward trend in earnings estimates for fiscal 2026 is a significant positive catalyst; investors should monitor for continued positive revisions as a potential trigger for a ratings upgrade and share price appreciation.
• Given the conflicting signals of a #3 (Hold) rank and strong growth metrics, a prudent approach could be to initiate a partial position or await a more favorable entry point, using the neutral rating as a reason for cautious position sizing rather than outright dismissal.